PDCD1 and neoplasm: Furthermore, when prom-M/F was combined with anti-PD-1 treatment, it demonstrated excellent antitumor effects, with complete tumor suppression achieved in six (75%) of the eight mice (75%) treated with the combination (Wang et al., 2021c).